Private Capital Advisors, Inc. Eli Lilly & CO Transaction History

Private Capital Advisors, Inc.

$898 Million
Q2 2024

A detailed history of Private Capital Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Private Capital Advisors, Inc. holds 433,307 shares of LLY stock, worth $360 Million. This represents 43.69% of its overall portfolio holdings.

Number of Shares

433,307

Previous 430,014 0.77%

Holding current value

$360 Million

Previous $335 Million 17.27%

% of portfolio

43.69%

Previous 41.66%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $2.39 Million - $2.99 Million	3,293 Added 0.77%	433,307 $392 Million
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $5.29 Million - $7.07 Million	8,927 Added 2.12%	430,014 $335 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $23.2 Million - $27.3 Million	-44,161 Reduced 9.49%	421,087 $245 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2.35 Million - $3.24 Million	5,411 Added 1.18%	465,248 $258 Million
Q2 2023 Jul 28, 2023	BUY	$350.74 - $468.98 $4.24 Million - $5.67 Million	12,088 Added 2.7%	459,837 $216 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $21,744 - $25,537	70 Added 0.02%	447,749 $154 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $2.26 Million - $2.63 Million	7,016 Added 1.59%	447,679 $164 Million
Q2 2022 Jul 21, 2022	BUY	$278.73 - $327.27 $2.27 Million - $2.67 Million	8,155 Added 1.89%	440,663 $143 Million
Q1 2022 Apr 22, 2022	BUY	$234.69 - $291.66 $602,449 - $748,691	2,567 Added 0.6%	432,508 $124 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $3.48 Million - $4.32 Million	15,465 Added 3.73%	429,941 $119 Million
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $1.92 Million - $2.36 Million	8,657 Added 2.13%	414,476 $95.8 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $6.33 Million - $8.19 Million	35,055 Added 9.45%	405,819 $93.1 Million
Q4 2020 Jan 15, 2021	BUY	$130.46 - $172.63 $4.7 Million - $6.22 Million	36,040 Added 10.77%	370,764 $62.6 Million
Q2 2020 Jul 28, 2020	SELL	$136.42 - $164.18 $136,420 - $164,180	-1,000 Reduced 0.3%	334,724 $55 Million
Q1 2020 Apr 15, 2020	BUY	$119.05 - $147.35 $20,833 - $25,786	175 Added 0.05%	335,724 $46.6 Million
Q3 2019 Oct 15, 2019	BUY	$106.79 - $116.16 $5.34 Million - $5.81 Million	50,000 Added 17.51%	335,549 $37.5 Million
Q3 2018 Oct 16, 2018	SELL	$85.86 - $107.31 $8.84 Million - $11.1 Million	-102,990 Reduced 26.51%	285,549 $30.6 Million
Q3 2018 Oct 12, 2018	BUY	$85.86 - $107.31 $256,721 - $320,856	2,990 Added 0.78%	388,539 $33.2 Million
Q4 2017 Jan 12, 2018	SELL	$81.94 - $87.89 $245,000 - $262,791	-2,990 Reduced 0.77%	385,549 $32.6 Million
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $29.9 Million - $33.2 Million	388,539	388,539 $33.2 Million

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.95M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $788B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Advisors, Inc. with notifications on news.

Account

Private Capital Advisors, Inc. Eli Lilly & CO Transaction History